BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14624075)

  • 1. Primary central nervous system lymphomas.
    Batara JF; Grossman SA
    Curr Opin Neurol; 2003 Dec; 16(6):671-5. PubMed ID: 14624075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
    Shah AC; Kelly DR; Nabors LB; Oakes WJ; Hilliard LM; Reddy AT
    Pediatr Blood Cancer; 2010 Dec; 55(6):1227-30. PubMed ID: 20882580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
    González-Aguilar A; Soto-Hernández JL
    Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
    Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
    Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.
    Nguyen PL; Chakravarti A; Finkelstein DM; Hochberg FH; Batchelor TT; Loeffler JS
    J Clin Oncol; 2005 Mar; 23(7):1507-13. PubMed ID: 15735126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time?
    Utsuki S; Oka H; Miyajima Y; Kijima C; Yasui Y; Fujii K
    Brain Tumor Pathol; 2011 Apr; 28(2):145-9. PubMed ID: 21327439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
    Shenkier TN; Voss N; Chhanabhai M; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Morris J; O'Reilly SE; Pickles T; Sehn L; Connors JM
    Cancer; 2005 Mar; 103(5):1008-17. PubMed ID: 15651059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary CNS lymphoma.
    Gerstner E; Batchelor T
    Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system lymphoma.
    Stern JI; Raizer JJ
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S63-70. PubMed ID: 16274272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system lymphoma.
    Abrey LE
    Curr Opin Neurol; 2009 Dec; 22(6):675-80. PubMed ID: 19741527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
    Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
    Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary CNS lymphoma--an update].
    Soussain C; Houillier C; Choquet S; Hoang-Xuan K
    Bull Cancer; 2014 Mar; 101(3):314-24. PubMed ID: 24691194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate.
    Reni M; Mazza E; Foppoli M; Ferreri AJ
    Cancer Lett; 2007 Dec; 258(2):165-70. PubMed ID: 17993246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).
    O'Brien PC; Roos DE; Pratt G; Liew KH; Barton MB; Poulsen MG; Olver IN; Trotter GE;
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):408-13. PubMed ID: 16198065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphoma: recent progress, many remaining questions.
    Swinnen LJ
    Curr Opin Oncol; 2009 Sep; 21(5):393-6. PubMed ID: 19593137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of primary central nervous system lymphoma].
    Gonzalez-Aguilar A; Houillier C; Soussain C; Hoang-Xuan K
    Rev Neurol (Paris); 2011 Oct; 167(10):721-8. PubMed ID: 21906768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for radiotherapy in the primary management of primary central nervous system lymphoma? A single-centre case series.
    Muirhead R; Murray EC; Bell SL; Stewart W; James A
    Clin Oncol (R Coll Radiol); 2013 Jul; 25(7):400-5. PubMed ID: 23688624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.